Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lundberg Sven Ante Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 Lundberg Sven Ante (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Lundberg Sven Ante (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 16,911 options to buy @ $4.26, valued at $72k
02/02/2022 4 Lundberg Sven Ante (President, CEO & PFO) has filed a Form 4 on Merus N.V.
Txns: Granted 295,000 options to buy @ $24.61, valued at $7.3M
08/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
01/06/2020 4 Lundberg Sven Ante (President, CEO & PFO) has filed a Form 4 on Merus N.V.
Txns: Granted 414,917 options to buy @ $13.52, valued at $5.6M
01/02/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
02/10/2017 4 Lundberg Sven Ante (Chief Scientific Officer) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Converted 55,217 shares @ $0
Bought 400 shares @ $14, valued at $5.6k
Converted 55,217 options to buy @ $0
10/18/2016 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy